Altamira Therapeutics Provides Year-End 2022 Business Update; Promoted Covadonga Pañeda, From Chief Development Officer To Chief Operating Officer
Altamira Therapeutics Provides Year-End 2022 Business Update
Strategic BentrioTM partnering or divestiture process enters decisive phase
Partnering or divestiture process for inner ear